IP Library Granted Patent US 9,724,233
Granted Patent B2
US 9,724,233 · App. 14/685,206 · Granted Aug 8, 2017

Method and apparatus for the delivery of photo-chemical (cross-linking) treatment to scleral tissue

Inventors: Mark S. Blumenkranz (Portola Valley, CA); Edward E. Manche (Los Altos, CA); Satish V. Herekar (Palo Alto, CA); Donald J. Eaton (Los Altos, CA)
A61F9/0017A61F9/0079A61K9/0051A61K31/525A61K41/0038A61K41/0057A61N5/062
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,724,233
App. No.
14/685,206
Granted
Aug 8, 2017
Kind
B2
Abstract

Delivery systems and methods for delivering riboflavin (R/F) and UVA irradiation to the sclera are disclosed. The R/F is delivered and then activated with UVA irradiation through the use of LEDs or optical fibers, thereby causing cross-linking of the collagen tissue. Delivery systems include implantable structures which provide surfaces that conform to the sclera. The delivery systems include various types of structures for delivery of R/F onto the sclera surface. Additionally, the delivery systems include UVA sources which provide irradiation of R/F in sclera collagen tissue.

Claims (10)

1. A system for treatment of an equatorial region of the sclera comprising:

a cylindrical apparatus having an outer convex surface and an inner concave surface, wherein the apparatus is shaped so that the inner concave surface conforms to the equatorial region of a sclera of an eye when disposed around the equatorial region; and

UVA sources embedded in the inner concave surface of the apparatus for delivering UVA irradiation to the sclera surface of the equatorial region of the sclera of an eye exposed to riboflavin (R/F) fluid,

wherein the apparatus is shaped and sized to be inserted around the equatorial region of the sclera and beneath the four rectus muscles of the sclera and applied to the surface of the sclera.

2. The system of claim 1 , further comprising channels within the apparatus for transporting and delivering R/F fluid to the sclera surface of the equatorial region of the sclera of an eye for transporting R/F fluid within the apparatus.

3. A system for treatment of an equatorial region of the sclera comprising:

a cylindrical apparatus having an outer convex surface and an inner concave surface, wherein the apparatus is shaped so that the inner concave surface conforms to the equatorial region of a sclera of an eye when disposed around the equatorial region; and

UVA sources embedded in the inner concave surface of the apparatus for delivering UVA irradiation to the to the sclera surface of the equatorial region of the sclera of an eye exposed to riboflavin (R/F) fluid,

wherein the apparatus has a slit in a wall of the apparatus extending longitudinally along its entire length from a top end to a bottom end forming two ends, wherein the two ends are joined in use to seal the apparatus.

4. The system of claim 3 , further comprising channels within the apparatus for transporting and delivering R/F fluid to the sclera surface of the equatorial region of the sclera of an eye for transporting R/F fluid within the apparatus.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 1, 2019
From: DAVID A. BREWER TRUST
To: ALEYEGN TECHNOLOGIES LLC
Reel/Frame 048759/0320 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 27, 2019
From: SEROS MEDICAL, LLC
To: DAVID A. BREWER TRUST
Reel/Frame 048711/0747 →
Continuity (3)
Division 13396454 · Feb 14, 2012
Provisional Application 61443191 · Feb 15, 2011
Related Publication 20150320595A1 · Nov 12, 2015